Share this page on LinkedIn
Share This Page on Google+
Share This Page on Twitter
tell someone about this page print this page
You are here: Contents > 2013 > Volume 22 Number 2 March > DEVICE EVALUATION > Short-Term and Mid-Term Results with the Sorin Freedom Solo Aortic Valve

Short-Term and Mid-Term Results with the Sorin Freedom Solo Aortic Valve

Hasim Ustunsoy, Alptekin Yasim, Hayati Deniz, Gokhan Gokaslan, Ozerdem Ozcaliskan

Gaziantep University Faculty of Medicine, Cardiovascular Surgery Department, Gaziantep, Turkey

Background and aim of the study: The study aim was to present the short- and mid-term results for patients who underwent aortic valve replacement (AVR) with the Sorin Freedom Solo third-generation stentless prosthetic valve.

Methods: AVR with a Sorin Freedom Solo valve was performed in 14 patients between March 2006 and March 2011. Patients aged ≥ 60 years (male:female ratio 6:8; mean age 73.28 ± 5.42 years) who required AVR with the Sorin Freedom Solo valve according to the surgeon’s choice were included in the study. The valvular prosthesis was implanted in the supra-annular position, using a single suture line. 

Results: Eight patients underwent an isolated AVR; combined interventions were carried out in the other patients due to concomitant cardiac disease. One patient died during the immediate perioperative period, and two more during the follow up, from non-cardiac causes. The mean maximum transvalvular gradient of patients with aortic stenosis was 88.1 ± 20.2 mmHg, and this fell to 26.4 ± 7.6 mmHg during the early postoperative period. The mean gradient at one year of follow up was further decreased to 19.4 ± 5.3 mmHg. The left ventricular end-diastolic and end-systolic diameters were also significantly reduced, from 4.8 ± 0.9 to 4.3 ± 0.6 cm and from 3.2 ± 0.6 to 2.8 ± 5.3 cm, respectively. The average left ventricular ejection fraction was 60.2 ± 4.9% preoperatively, and 63.2 ± 2.1% at one year after surgery (p = NS). No paravalvular leakage, endocarditis, prosthesis failure or neurologic events were reported among patients.

Conclusion: The Sorin Freedom Solo stentless valve has provided good early and intermediate-term results. Implantation of the prosthesis is straightforward, with low rates of morbidity and mortality. However, these data require further support from larger patient series and long-term follow up.


The Journal of Heart Valve Disease 2013;22:215-221

Short-Term and Mid-Term Results with the Sorin Freedom Solo Aortic Valve

Click the above hyperlink to view the article, right click (Ctrl click on a Mac) to open in a new browser window or tab.

Purchase this Article

Please click the button below to purchase this article. Single article purchases are provided at $50.00 per article. Upon clicking the button below, single article user account subscription details are requested and, upon successful payment, a single article user account is created. Single articles are availble in your account for seven days after purchase.